Understanding the NICE severity premium: Exploring its implementation and the implications for decision-making and patient access

Research output: Contribution to journal › Article › peer-review

Access to Document

Published version
© 2024 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.
Accepted author manuscript, 817 KBLicence: CC BY

@article{73bbca9408cd487e9b7a3b5cb7a43c95,

title = "Understanding the NICE severity premium: Exploring its implementation and the implications for decision-making and patient access",

author = "Njoroge, {Martin Wanyoike} and Walton, {Matthew James} and Robert Hodgson",

note = "{\textcopyright} 2024 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.",

year = "2024",

month = mar,

day = "4",

doi = "10.1016/j.jval.2024.02.013",

language = "English",

volume = "27",

pages = "730 -- 736",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Understanding the NICE severity premium

T2 - Exploring its implementation and the implications for decision-making and patient access

AU - Njoroge, Martin Wanyoike

AU - Walton, Matthew James

AU - Hodgson, Robert

PY - 2024/3/4

Y1 - 2024/3/4

U2 - 10.1016/j.jval.2024.02.013

DO - 10.1016/j.jval.2024.02.013

M3 - Article

SN - 1098-3015

VL - 27

SP - 730

EP - 736

JO - Value in Health

JF - Value in Health

IS - 6

ER -